News

2021 Guest User 2021 Guest User

Bristol Myers Squib

Bristol Myers Squibb Receives European Commission Approval for Inrebic® (fedratinib) for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis

Read Article

Read More